The Abbvie shows a gross margin of 73.7%, an operating margin of 32.2%, an EBITDA margin of 35.1%, and a net margin of 15.7%. Operating margin drove the improvement across the available margins, increasing by 17 percentage points.
Over the last 3 years, Abbvie's margins averaged 68.51% gross, 22.45% operating, 28.42% EBITDA, and 8.54% net. All four current margins are above their three-year averages.
The biggest expansion was in operating margin, which rose by 17 percentage points. The other available margins also improved.
Throughout the last 3 years, Abbvie had an average gross margin of 68.51%. Against its three-year average, Abbvie's gross margin is currently 73.7%, 5.2 percentage points above its three-year average. Looking back over the last 3 years, Abbvie's gross margin reached 73.7% at its highest point in Sep 2026 and 62.3% at its lowest in Mar 2024.
Over the last 3 years, Abbvie's operating margin averaged 22.45%. The current operating margin of 32.2% is 9.8 percentage points above its three-year average. During this period, operating margin reached a high of 32.2% in Sep 2026 and a low of 15.2% in Sep 2025.
Looking at the last 3 years, Abbvie had an average EBITDA margin of 28.42%. As of the latest period, Abbvie's current EBITDA margin is 35.1%, which is 6.7 percentage points above its three-year average. Looking back over the last 3 years, Abbvie's EBITDA margin reached 35.1% at its highest point in Sep 2026 and 20.9% at its lowest in Sep 2025.
Across the last 3 years, Abbvie's net margin came to 8.54%. The current net margin stands at 15.7%, 7.2 percentage points above its three-year average. Net margin was highest at 15.7% in Sep 2026 and lowest at 4% in Sep 2025.
With a gross margin of 73.7%, ABBV is above the Healthcare sector and the industry average but below its peers average. Compared to its Healthcare sector average of 68.3%, Abbvie's gross margin is 8% higher.
For the period ending Sep 30, 2026, ABBV recorded a gross margin of 73.7%.
For the period ending Sep 30, 2026, ABBV recorded an operating margin of 32.2%.
As of Sep 30, 2026, ABBV has an EBITDA margin of 35.1%.
The current net margin for ABBV is 15.7% as of Sep 30, 2026.
Over the past 3 years, ABBV reported average margins of 68.5% gross, 22.5% operating, 28.4% EBITDA, and 8.5% net.
In the last 5 years, the highest margins reported by ABBV were 73.7% gross in Sep 2026, 32.7% operating in Mar 2022, 43.6% EBITDA in Sep 2022, and 23.2% net in Sep 2022.
Abbvie's lowest recorded margins during the past 5 years were 62.3% gross in Mar 2024, 15.2% operating in Sep 2025, 20.9% EBITDA in Sep 2025, and 4% net in Sep 2025.